Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (101-110 of 284) with videos related to

Pageof 29
Sort By:
European Journal of Clinical Pharmacology|August 26, 2003
Xanthine oxidase activity is influenced by environmental factors in EthiopiansEleni Aklillu, Juan Antonio Carrillo, Eyasu Makonnen, et al.
Frontiers in Psychiatry|April 1, 2020
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?Roos van Westrhenen, Katherine J Aitchison, Magnus Ingelman-Sundberg, et al.
British Journal of Clinical Pharmacology|October 13, 2018
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patientsTore Haslemo, Erik Eliasson, Marin M Jukić, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2020
A 3D Cell Culture Model Identifies Wnt/<i>β</i>-Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte RegenerationNuria Oliva-Vilarnau, Sabine U Vorrink, Magnus Ingelman-Sundberg, et al.
Pharmacogenetics|July 27, 2002
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in SwedenEleni Aklillu, Karin Herrlin, Lars L Gustafsson, et al.
Pharmacogenetics and Genomics|July 26, 2005
CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C alleleSarah C Sim, Robert J Edwards, Alan R Boobis, et al.
The Journal of Biological Chemistry|June 7, 2005
A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al.
Cancer Research|June 17, 2005
Characterization of common CYP1B1 variants with different capacity for benzo[a]pyrene-7,8-dihydrodiol epoxide formation from benzo[a]pyreneEleni Aklillu, Steinar Øvrebø, Ingrid V Botnen, et al.
Hepatology Communications|February 15, 2024
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH modelSander van Riet, Anais Julien, Andrea Atanasov, et al.
Archives of Biochemistry and Biophysics|December 18, 2002
Hemin-mediated restoration of allylisopropylacetamide-inactivated CYP2B1: a role for glutathione and GRP94 in the heme-protein assemblyVictor Gavrilovich Zgoda, Byron Arison, Souren Mkrtchian, et al.
Pageof 29

Showing results (101-110 of 284) with videos related to

Sort By:
Pageof 29
European Journal of Clinical Pharmacology|August 26, 2003
Xanthine oxidase activity is influenced by environmental factors in EthiopiansEleni Aklillu, Juan Antonio Carrillo, Eyasu Makonnen, et al.
Frontiers in Psychiatry|April 1, 2020
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?Roos van Westrhenen, Katherine J Aitchison, Magnus Ingelman-Sundberg, et al.
British Journal of Clinical Pharmacology|October 13, 2018
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patientsTore Haslemo, Erik Eliasson, Marin M Jukić, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2020
A 3D Cell Culture Model Identifies Wnt/<i>β</i>-Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte RegenerationNuria Oliva-Vilarnau, Sabine U Vorrink, Magnus Ingelman-Sundberg, et al.
Pharmacogenetics|July 27, 2002
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in SwedenEleni Aklillu, Karin Herrlin, Lars L Gustafsson, et al.
Pharmacogenetics and Genomics|July 26, 2005
CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C alleleSarah C Sim, Robert J Edwards, Alan R Boobis, et al.
The Journal of Biological Chemistry|June 7, 2005
A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al.
Cancer Research|June 17, 2005
Characterization of common CYP1B1 variants with different capacity for benzo[a]pyrene-7,8-dihydrodiol epoxide formation from benzo[a]pyreneEleni Aklillu, Steinar Øvrebø, Ingrid V Botnen, et al.
Hepatology Communications|February 15, 2024
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH modelSander van Riet, Anais Julien, Andrea Atanasov, et al.
Archives of Biochemistry and Biophysics|December 18, 2002
Hemin-mediated restoration of allylisopropylacetamide-inactivated CYP2B1: a role for glutathione and GRP94 in the heme-protein assemblyVictor Gavrilovich Zgoda, Byron Arison, Souren Mkrtchian, et al.
Pageof 29